Due to the fact that high lactate levels [18] and high HSP levels can increase the radioresistance of tumor cells [19], and LDH inhibition affects both the lactate and HSP system, LDH inhibition might provide a promising strategy to improve the clinical outcome of patients with highly aggressive, therapy-resistant tumors. The gene discussed is HSP90B2P; the disease is neoplasm.